Deutsche Bank upgrades bioMérieux to buy and raises target to €103
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- Deutsche Bank upgraded French diagnostics company bioMérieux to "buy" from "hold" and raised its price target to €103 from €75, saying an earlier start to the U.S. flu season has reduced the risk to the company's 2026 guidance. Still guessing which stocks will…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishReduced guidance risk from an early flu season may support this diagnostics mid-cap.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Deutsche Bank raised its price target from €75 to €103.
- 02An earlier US flu season reduces the risk to the 2026 guidance.
- 03The broker cautioned that absolute numbers remain low and an early start does not mean a stronger season.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets